Burning Rock Biotech Ltd (BNR) — Cash Flow-to-Debt Ratio
Burning Rock Biotech Ltd (BNR) has a Cash Flow-to-Debt Ratio of 0.08x as of March 2026, meaning its operating cash flow of $23.04 Million could theoretically repay 0% of its total liabilities ($285.29 Million) in one year. See Burning Rock Biotech Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Burning Rock Biotech Ltd Cash Flow-to-Debt Ratio (2017–2025)
Historical debt coverage capacity for Burning Rock Biotech Ltd across 9 annual periods. Also explore Burning Rock Biotech Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Burning Rock Biotech Ltd (2017–2025)
Year-by-year debt coverage analysis for Burning Rock Biotech Ltd. For market capitalisation and broader financial context, see Burning Rock Biotech Ltd (BNR) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.10x | $-28.44 Million | $285.29 Million | ▲ +67.1% |
| 2024 | -0.30x | $-92.26 Million | $304.48 Million | ▲ +67.8% |
| 2023 | -0.94x | $-255.78 Million | $271.59 Million | ▲ +11.5% |
| 2022 | -1.06x | $-456.81 Million | $429.13 Million | ▲ +3.5% |
| 2021 | -1.10x | $-477.89 Million | $433.28 Million | ▼ -263.0% |
| 2020 | -0.30x | $-73.54 Million | $242.02 Million | ▼ -131.7% |
| 2019 | -0.13x | $-228.04 Million | $1.74 Billion | ▲ +14.0% |
| 2018 | -0.15x | $-148.78 Million | $976.14 Million | ▲ +73.6% |
| 2017 | -0.58x | $-133.70 Million | $231.85 Million | — |